BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7729953)

  • 1. Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genes.
    Vikhanskaya F; D'Incalci M; Broggini M
    Int J Cancer; 1995 May; 61(3):397-401. PubMed ID: 7729953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F; Erba E; D'Incalci M; Broggini M
    Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
    Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ
    Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and cellular response to different anticancer agents of a human ovarian cancer cell line expressing wild-type, mutated or no p53.
    Graniela Sirè EA; Vikhanskaya F; Broggini M
    Ann Oncol; 1995 Jul; 6(6):589-93. PubMed ID: 8573539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53.
    Vikhanskaya F; Erba E; D'Incalci M; Broggini M
    Nucleic Acids Res; 1994 Mar; 22(6):1012-7. PubMed ID: 8152906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
    Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
    Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced sensitivity to cis-diamminedichloroplatinum(II) of a human carcinoma cell line with mutated p53 gene by cyclin-dependent kinase inhibitor p21(WAF1) expression.
    Satou M; Aizawa S; Hayakari M; Ookawa K; Tsuchida S
    Cancer Sci; 2003 Mar; 94(3):286-91. PubMed ID: 12824923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D; Siré EG; De Feudis P; Vikhanskaya F; Valenti M; Russo P; Parodi S; D'Incalci M; Broggini M
    Cancer Res; 1997 Mar; 57(5):870-4. PubMed ID: 9041188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].
    Jiang M; Shao Z; Wu J
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):181-4. PubMed ID: 10921001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
    Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
    DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.
    De Feudis P; Debernardis D; Beccaglia P; Valenti M; Graniela Siré E; Arzani D; Stanzione S; Parodi S; D'Incalci M; Russo P; Broggini M
    Br J Cancer; 1997; 76(4):474-9. PubMed ID: 9275024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.
    O'Connor PM; Jackman J; Bae I; Myers TG; Fan S; Mutoh M; Scudiero DA; Monks A; Sausville EA; Weinstein JN; Friend S; Fornace AJ; Kohn KW
    Cancer Res; 1997 Oct; 57(19):4285-300. PubMed ID: 9331090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    el-Deiry WS; Harper JW; O'Connor PM; Velculescu VE; Canman CE; Jackman J; Pietenpol JA; Burrell M; Hill DE; Wang Y
    Cancer Res; 1994 Mar; 54(5):1169-74. PubMed ID: 8118801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.
    Zhang W; Grasso L; McClain CD; Gambel AM; Cha Y; Travali S; Deisseroth AB; Mercer WE
    Cancer Res; 1995 Feb; 55(3):668-74. PubMed ID: 7834638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.
    Kondo S; Barna BP; Kondo Y; Tanaka Y; Casey G; Liu J; Morimura T; Kaakaji R; Peterson JW; Werbel B; Barnett GH
    Oncogene; 1996 Sep; 13(6):1279-85. PubMed ID: 8808702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells.
    Ding H; Duan W; Zhu WG; Ju R; Srinivasan K; Otterson GA; Villalona-Calero MA
    Biochem Biophys Res Commun; 2003 Jun; 305(4):950-6. PubMed ID: 12767922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.